129 related articles for article (PubMed ID: 3560164)
21. Conformational analysis of CCK-B agonists using 1H-NMR and restrained molecular dynamics: comparison of biologically active Boc-Trp-(N-Me) Nle-Asp-Phe-NH2 and inactive Boc-Trp-(N-Me)Phe-Asp-Phe-NH2.
Goudreau N; Weng JH; Roques BP
Biopolymers; 1994 Feb; 34(2):155-69. PubMed ID: 8142585
[TBL] [Abstract][Full Text] [Related]
22. CCK-A receptor selective antagonists derived from the CCK-A receptor selective tetrapeptide agonist Boc-Trp-Lys(Tac)-Asp-MePhe-NH2 (A-71623).
Sugg EE; Kimery MJ; Ding JM; Kenakin DC; Miller LJ; Queen KL; Rimele TJ
J Med Chem; 1995 Jan; 38(1):207-11. PubMed ID: 7837233
[TBL] [Abstract][Full Text] [Related]
23. Novel Asp32-replacement tetrapeptide analogues as potent and selective CCK-A agonists.
Elliott RL; Kopecka H; Tufano MD; Shue YK; Gauri AJ; Lin CW; Bianchi BR; Miller TR; Witte DG; Stashko MA
J Med Chem; 1994 May; 37(11):1562-8. PubMed ID: 8201590
[TBL] [Abstract][Full Text] [Related]
24. Enzyme-resistant CCK analogs with high affinities for central receptors.
Charpentier B; Durieux C; Pelaprat D; Dor A; Reibaud M; Blanchard JC; Roques BP
Peptides; 1988; 9(4):835-41. PubMed ID: 3226959
[TBL] [Abstract][Full Text] [Related]
25. Replacement of glycine with dicarbonyl and related moieties in analogues of the C-terminal pentapeptide of cholecystokinin: CCK(2) agonists displaying a novel binding mode.
Bellier B; Million ME; DaNascimento S; Meudal H; Kellou S; Maigret B; Garbay C
J Med Chem; 2000 Oct; 43(20):3614-23. PubMed ID: 11020275
[TBL] [Abstract][Full Text] [Related]
26. On the biologically active structures of cholecystokinin, little gastrin, and enkephalin in the gastrointestinal system.
Pincus MR; Carty RP; Chen J; Lubowsky J; Avitable M; Shah D; Scheraga HA; Murphy RB
Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4821-5. PubMed ID: 3037525
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of gastrin antagonists, analogues of the C-terminal tetrapeptide of gastrin, by introduction of a beta-homo residue.
Rodriguez M; Fulcrand P; Laur J; Aumelas A; Bali JP; Martinez J
J Med Chem; 1989 Mar; 32(3):522-8. PubMed ID: 2918498
[TBL] [Abstract][Full Text] [Related]
28. Carboxylic acids and tetrazoles as isosteric replacements for sulfate in cholecystokinin analogues.
Tilley JW; Danho W; Lovey K; Wagner R; Swistok J; Makofske R; Michalewsky J; Triscari J; Nelson D; Weatherford S
J Med Chem; 1991 Mar; 34(3):1125-36. PubMed ID: 2002454
[TBL] [Abstract][Full Text] [Related]
29. Development of CCK-B antagonists.
Horwell DC
Neuropeptides; 1991 Jul; 19 Suppl():57-64. PubMed ID: 1881533
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of analogues of the Des-Phe-NH2 C-terminal hexapeptide of cholecystokinin showing gastrin antagonist activity.
Laur J; Rodriguez M; Aumelas A; Bali JP; Martinez J
Int J Pept Protein Res; 1986 Apr; 27(4):386-93. PubMed ID: 3710694
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological activity of partially modified retro-inverso pseudopeptide derivatives of the C-terminal tetrapeptide of gastrin.
Rodriguez M; Dubreuil P; Bali JP; Martinez J
J Med Chem; 1987 May; 30(5):758-63. PubMed ID: 3572963
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of cyclic analogues of cholecystokinin highly selective for central receptors.
Rodriguez M; Amblard M; Galas MC; Lignon MF; Aumelas A; Martinez J
Int J Pept Protein Res; 1990 May; 35(5):441-51. PubMed ID: 2376470
[TBL] [Abstract][Full Text] [Related]
33. Products of cholecystokinin (CCK)-octapeptide proteolysis interact with central CCK receptors.
Steardo L; Knight M; Tamminga CA; Chase TN
Neurosci Lett; 1985 Mar; 54(2-3):319-25. PubMed ID: 2986058
[TBL] [Abstract][Full Text] [Related]
34. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
Lin CW; Shiosaki K; Miller TR; Witte DG; Bianchi BR; Wolfram CA; Kopecka H; Craig R; Wagenaar F; Nadzan AM
Mol Pharmacol; 1991 Mar; 39(3):346-51. PubMed ID: 1706470
[TBL] [Abstract][Full Text] [Related]
35. High affinity binding of cholecystokinin to small cell lung cancer cells.
Yoder DG; Moody TW
Peptides; 1987; 8(1):103-7. PubMed ID: 3033616
[TBL] [Abstract][Full Text] [Related]
36. [Design and synthesis of cholecystokinin-4 dipeptide analogues with anxiolytic and anxiogenic activities].
Gudasheva TA; Kir'ianova EP; Kolik LG; Konstantinopol'skiĭ MA; Seredenin SB
Bioorg Khim; 2007; 33(4):413-20. PubMed ID: 17886432
[TBL] [Abstract][Full Text] [Related]
37. Novel activity of angiotensin-converting enzyme. Hydrolysis of cholecystokinin and gastrin analogues with release of the amidated C-terminal dipeptide.
Dubreuil P; Fulcrand P; Rodriguez M; Fulcrand H; Laur J; Martinez J
Biochem J; 1989 Aug; 262(1):125-30. PubMed ID: 2554881
[TBL] [Abstract][Full Text] [Related]
38. Degradation of cholecystokinin-like peptides by a crude rat brain synaptosomal fraction: a study by high pressure liquid chromatography.
Deschodt-Lanckman M; Bui ND; Noyer M; Christophe J
Regul Pept; 1981 Apr; 2(1):15-30. PubMed ID: 6262880
[TBL] [Abstract][Full Text] [Related]
39. 2-Oxopiperazine-based gamma-turn conformationally constrained peptides: synthesis of CCK-4 analogues.
Herrero S; García-López MT; Latorre M; Cenarruzabeitia E; Del Río J; Herranz R
J Org Chem; 2002 May; 67(11):3866-73. PubMed ID: 12027705
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological activity of CCK heptapeptide analogues. Effects of conformational constraints and standard modifications on receptor subtype selectivity, functional activity in vitro, and appetite suppression in vivo.
Holladay MW; Bennett MJ; Tufano MD; Lin CW; Asin KE; Witte DG; Miller TR; Bianchi BR; Nikkel AL; Bednarz L
J Med Chem; 1992 Aug; 35(16):2919-28. PubMed ID: 1501220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
